Cargando…
The AIDS malignancy clinical trials consortium (AMC) patient navigator (PN) initiative
Autores principales: | Botello-Harbaum, Maria T, Mosby, Kimberly, Vena, Don, Aboulafia, David M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3330067/ http://dx.doi.org/10.1186/1750-9378-7-S1-P24 |
Ejemplares similares
-
Assessing clinical investigators’ perceptions of relevance and competency of clinical trials skills: An international AIDS Malignancy Consortium (AMC) study
por: Lee, Jeannette Y., et al.
Publicado: (2020) -
Safety and Tolerability of Carboplatin and Paclitaxel in Cancer Patients with HIV (AMC-078), an AIDS Malignancy Consortium (AMC) Study
por: Haigentz, Missak, et al.
Publicado: (2022) -
Phase II AIDS Malignancy Consortium (AMC) trial of imatinib in AIDS-associated Kaposi’s sarcoma (KS)
por: Koon, Henry B, et al.
Publicado: (2010) -
A phase 1/PK study of Sunitinib with highly active antiretroviral therapy (HAART) in HIV+ patients with solid tumors: AIDS malignancy consortium study 061
por: Deeken, John F, et al.
Publicado: (2012) -
Immunophenotypic analysis of AIDS-related diffuse large B-cell lymphoma and clinical implications in patients from AIDS malignancies consortium clinical trials 010 and 034
por: Chadburn, A, et al.
Publicado: (2009)